Prometheus v. Mayo has had its day at the Supreme Court, but the Court has yet to render a verdict. This leaves everyone with a couple of months on their hands to speculate as to what the outcome might be. Let's take a quick look at some of the opinions that have been offered on this subject. In a Dec. 8 posting at IPWatchdog.com, attorney Ryan Chiromas of Westerman Hattori Daniels & Adrian (Washington) said he was “surprised at how little Bilski was mentioned,” a reference to the business method patents case that seemed to send the message that...
Screening for various diseases is controversial these days thanks to the U.S. Public Services Task Force and similar agencies in other nations, which have suggested a more cautious approach to screening. These suggestions have been blasted by doctors and patient groups for obvious reasons. Former Medical Device Daily executive editor Jim Stommen took up prostate cancer screening in a posting at this blog a few weeks back, and while I agree with Jim on a lot of things, I felt one perspective was missing; that of the federal budget. The problem is that no national economy can support indiscriminate...
